Vanessa L. Cook
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vanessa L. Cook has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anthony T. Blikslager
Department of Clinical Sciences North Carolina State University Raleigh North Carolina USA
4 shared publications Nigel B. Campbell
2 shared publicationsChristine M. Corl
Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA
1 shared publicationColleen T. Meyer
1 shared publication- Diana M. Hassel
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA
1 shared publication Jeffrey C. Gandy
Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA
1 shared publication
Latest Publications
- 17 December 2014
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 25 (1) , 76-88
The use of nonsteroidal anti‐inflammatory drugs in critically ill horses
Objective: To review the physiology of the cyclooxygenase (COX) enzymes with reference to the beneficial effects of nonsteroidal anti‐inflammatory drugs (NSAIDs) related to their analgesic and antiendotoxic properties as well as the mechanisms responsible for adverse gastrointestinal, renal, and coagulation effects.Data Sources: Human and veterinary peer reviewed literatureVeterinary Data Synthesis: NSAIDs are frequently administered to critically ill horses for their analgesic and anti‐inflammatory effects. However, NSAIDs have significant side effects principally on the gastrointestinal mucosa and kidneys. These side effects may be exacerbated in critically ill horses if they have gastrointestinal damage or are volume depletedConclusions: This review provides important information for equine veterinarians and criticalists on the advantages and disadvantages of using traditional NSAIDs and newer equine COX‐2 selective NSAIDs for the management of different conditions in critically ill horses.
- 17 December 2014
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 25 (1) , 76-88
The use of nonsteroidal anti‐inflammatory drugs in critically ill horses
Objective: To review the physiology of the cyclooxygenase (COX) enzymes with reference to the beneficial effects of nonsteroidal anti‐inflammatory drugs (NSAIDs) related to their analgesic and antiendotoxic properties as well as the mechanisms responsible for adverse gastrointestinal, renal, and coagulation effects.Data Sources: Human and veterinary peer reviewed literatureVeterinary Data Synthesis: NSAIDs are frequently administered to critically ill horses for their analgesic and anti‐inflammatory effects. However, NSAIDs have significant side effects principally on the gastrointestinal mucosa and kidneys. These side effects may be exacerbated in critically ill horses if they have gastrointestinal damage or are volume depletedConclusions: This review provides important information for equine veterinarians and criticalists on the advantages and disadvantages of using traditional NSAIDs and newer equine COX‐2 selective NSAIDs for the management of different conditions in critically ill horses.
- 1 August 2014
- Published by Elsevier in Veterinary Clinics of North America: Equine Practice
- Vol. 30 (2)
Emergency and Critical Care
- 1 August 2014
- Published by Elsevier in Veterinary Clinics of North America: Equine Practice
- Vol. 30 (2)
Emergency and Critical Care
- 1 May 2011
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 141 (1-2) , 92-99
Ethyl pyruvate decreases proinflammatory gene expression in lipopolysaccharide-stimulated equine monocytes
- 1 May 2011
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 141 (1-2) , 92-99
Ethyl pyruvate decreases proinflammatory gene expression in lipopolysaccharide-stimulated equine monocytes
- 1 October 2009
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 70 (10) , 1259-1268
Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses
Objective—To investigate effects of lidocaine hydrochloride administered IV on mucosal inflammation in ischemia-injured jejunum of horses treated with flunixin meglumine. Animals—24 horses. Procedures—Horses received saline (0.9% NaCl) solution (SS; 1 mL/50 kg, IV [1 dose]), flunixin meglumine (1 mg/kg, IV, q 12 h), lidocaine (bolus [1.3 mg/kg] and constant rate infusion [0.05 mg/kg/min], IV, during and after recovery from surgery), or both flunixin and lidocaine (n = 6/group). During surgery, blood flow was occluded for 2 hours in 2 sections of jejunum in each horse. Uninjured and ischemia-injured jejunal specimens were collected after the ischemic period and after euthanasia 18 hours later for histologic assessment and determination of cyclooxygenase (COX) expression (via western blot procedures). Plasma samples collected prior to (baseline) and 8 hours after the ischemic period were analyzed for prostanoid concentrations. Results—Immediately after the ischemic period, COX-2 expression in horses treated with lidocaine alone was significantly less than expression in horses treated with SS or flunixin alone. Eighteen hours after the ischemic period, mucosal neutrophil counts in horses treated with flunixin alone were significantly higher than counts in other treatment groups. Compared with baseline plasma concentrations, postischemia prostaglandin E2 metabolite and thromboxane B2 concentrations increased in horses treated with SS and in horses treated with SS or lidocaine alone, respectively. Conclusions and Clinical Relevance—In horses with ischemia-injured jejunum, lidocaine administered IV reduced plasma prostaglandin E2 metabolite concentration and mucosal COX-2 expression. Coadministration of lidocaine with flunixin ameliorated the flunixin-induced increase in mucosal neutrophil counts.
- 1 October 2009
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 70 (10) , 1259-1268
Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses
Objective—To investigate effects of lidocaine hydrochloride administered IV on mucosal inflammation in ischemia-injured jejunum of horses treated with flunixin meglumine. Animals—24 horses. Procedures—Horses received saline (0.9% NaCl) solution (SS; 1 mL/50 kg, IV [1 dose]), flunixin meglumine (1 mg/kg, IV, q 12 h), lidocaine (bolus [1.3 mg/kg] and constant rate infusion [0.05 mg/kg/min], IV, during and after recovery from surgery), or both flunixin and lidocaine (n = 6/group). During surgery, blood flow was occluded for 2 hours in 2 sections of jejunum in each horse. Uninjured and ischemia-injured jejunal specimens were collected after the ischemic period and after euthanasia 18 hours later for histologic assessment and determination of cyclooxygenase (COX) expression (via western blot procedures). Plasma samples collected prior to (baseline) and 8 hours after the ischemic period were analyzed for prostanoid concentrations. Results—Immediately after the ischemic period, COX-2 expression in horses treated with lidocaine alone was significantly less than expression in horses treated with SS or flunixin alone. Eighteen hours after the ischemic period, mucosal neutrophil counts in horses treated with flunixin alone were significantly higher than counts in other treatment groups. Compared with baseline plasma concentrations, postischemia prostaglandin E2 metabolite and thromboxane B2 concentrations increased in horses treated with SS and in horses treated with SS or lidocaine alone, respectively. Conclusions and Clinical Relevance—In horses with ischemia-injured jejunum, lidocaine administered IV reduced plasma prostaglandin E2 metabolite concentration and mucosal COX-2 expression. Coadministration of lidocaine with flunixin ameliorated the flunixin-induced increase in mucosal neutrophil counts.
- 1 August 2009
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 235 (3) , 310
Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum
- 1 August 2009
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 235 (3) , 310
Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum
- 1 May 2009
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 129 (1-2) , 137-142
The effect of lidocaine on in vitro adhesion and migration of equine neutrophils
- 1 May 2009
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 129 (1-2) , 137-142
The effect of lidocaine on in vitro adhesion and migration of equine neutrophils